XML 75 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - Additional Information (Details)
$ in Millions
1 Months Ended 2 Months Ended 3 Months Ended
May 31, 2018
Patent
Dec. 31, 2016
USD ($)
Mar. 31, 2016
USD ($)
May 31, 2018
Patent
Sep. 30, 2016
USD ($)
Sep. 30, 2018
USD ($)
Feb. 28, 2018
Pending_Claim
Dec. 31, 2017
USD ($)
Loss Contingencies [Line Items]                
Damages awarded   $ 2,540            
Motion invalidated past damages, amount   $ 2,540            
Damages awarded but dismissed     $ 200          
Litigation accrual           $ 0   $ 0
Number of pending claims with motions to dismiss | Pending_Claim             2  
Merck '499 and '712 patents                
Loss Contingencies [Line Items]                
Damages awarded but dismissed, value         $ 200      
Aurobindo Pharma USA Inc V.S. Gilead Sciences, Inc                
Loss Contingencies [Line Items]                
Number of patents allegedly infringed | Patent       2        
Strides Pharma, Inc V.S. Gilead Sciences, Inc - Emtricitabine Patent                
Loss Contingencies [Line Items]                
Number of patents allegedly infringed | Patent 2              
Strides Pharma, Inc V.S. Gilead Sciences, Inc - Emtricitabine And Tenofovir Patent                
Loss Contingencies [Line Items]                
Number of patents allegedly infringed | Patent       4